206 related articles for article (PubMed ID: 28733476)
1. miR-30e targets GLIPR-2 to modulate diabetic nephropathy:
Zhao D; Jia J; Shao H
J Mol Endocrinol; 2017 Aug; 59(2):181-190. PubMed ID: 28733476
[TBL] [Abstract][Full Text] [Related]
2. miR-30b-5p modulate renal epithelial-mesenchymal transition in diabetic nephropathy by directly targeting SNAI1.
Wang Y; Liu Y; Zhang L; Bai L; Chen S; Wu H; Sun L; Wang X
Biochem Biophys Res Commun; 2021 Jan; 535():12-18. PubMed ID: 33383483
[TBL] [Abstract][Full Text] [Related]
3. MiR-30c protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition in db/db mice.
Zhao Y; Yin Z; Li H; Fan J; Yang S; Chen C; Wang DW
Aging Cell; 2017 Apr; 16(2):387-400. PubMed ID: 28127848
[TBL] [Abstract][Full Text] [Related]
4. Icariin inhibits epithelial mesenchymal transition of renal tubular epithelial cells via regulating the miR-122-5p/FOXP2 axis in diabetic nephropathy rats.
Zang L; Gao F; Huang A; Zhang Y; Luo Y; Chen L; Mao N
J Pharmacol Sci; 2022 Feb; 148(2):204-213. PubMed ID: 35063135
[TBL] [Abstract][Full Text] [Related]
5. miR-21 overexpression enhances TGF-β1-induced epithelial-to-mesenchymal transition by target smad7 and aggravates renal damage in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Wang P; Zhu ZY; Li JY; Zhou SN; Wang SC; Wang YY; Yang JK
Mol Cell Endocrinol; 2014 Jul; 392(1-2):163-72. PubMed ID: 24887517
[TBL] [Abstract][Full Text] [Related]
6. Effects and mechanism of miR-23b on glucose-mediated epithelial-to-mesenchymal transition in diabetic nephropathy.
Liu H; Wang X; Liu S; Li H; Yuan X; Feng B; Bai H; Zhao B; Chu Y; Li H
Int J Biochem Cell Biol; 2016 Jan; 70():149-60. PubMed ID: 26646104
[TBL] [Abstract][Full Text] [Related]
7. LncRNA MALAT1 facilities high glucose induced endothelial to mesenchymal transition and fibrosis via targeting miR-145/ZEB2 axis.
Liu B; Qiang L; Wang GD; Duan Q; Liu J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3478-3486. PubMed ID: 31081103
[TBL] [Abstract][Full Text] [Related]
8. MiR-30c-5p inhibits high glucose-induced EMT and renal fibrogenesis by down-regulation of JAK1 in diabetic nephropathy.
Gao BH; Wu H; Wang X; Ji LL; Chen C
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1338-1349. PubMed ID: 32096183
[TBL] [Abstract][Full Text] [Related]
9. Urotensin II Induces ER Stress and EMT and Increase Extracellular Matrix Production in Renal Tubular Epithelial Cell in Early Diabetic Mice.
Pang XX; Bai Q; Wu F; Chen GJ; Zhang AH; Tang CS
Kidney Blood Press Res; 2016; 41(4):434-49. PubMed ID: 27467277
[TBL] [Abstract][Full Text] [Related]
10. Chrysin inhibits diabetic renal tubulointerstitial fibrosis through blocking epithelial to mesenchymal transition.
Kang MK; Park SH; Choi YJ; Shin D; Kang YH
J Mol Med (Berl); 2015 Jul; 93(7):759-72. PubMed ID: 26062793
[TBL] [Abstract][Full Text] [Related]
11. Circ_WBSCR17 aggravates inflammatory responses and fibrosis by targeting miR-185-5p/SOX6 regulatory axis in high glucose-induced human kidney tubular cells.
Li G; Qin Y; Qin S; Zhou X; Zhao W; Zhang D
Life Sci; 2020 Oct; 259():118269. PubMed ID: 32798559
[TBL] [Abstract][Full Text] [Related]
12. LncRNA-NR_033515 promotes proliferation, fibrogenesis and epithelial-to-mesenchymal transition by targeting miR-743b-5p in diabetic nephropathy.
Gao J; Wang W; Wang F; Guo C
Biomed Pharmacother; 2018 Oct; 106():543-552. PubMed ID: 29990842
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-17 suppresses TGF-β1-mediated renal fibrosis through targeting Smad7.
Fu H; Chu D; Geng X
Mol Cell Biochem; 2021 Aug; 476(8):3051-3064. PubMed ID: 33797702
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-25 inhibits high glucose-induced apoptosis in renal tubular epithelial cells via PTEN/AKT pathway.
Li H; Zhu X; Zhang J; Shi J
Biomed Pharmacother; 2017 Dec; 96():471-479. PubMed ID: 29031207
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of miR-23a inhibits high glucose-induced EMT and renal fibrogenesis by up-regulation of SnoN.
Xu H; Sun F; Li X; Sun L
Hum Cell; 2018 Jan; 31(1):22-32. PubMed ID: 28707079
[TBL] [Abstract][Full Text] [Related]
16. LncRNA NEAT1 accelerates the occurrence and development of diabetic nephropathy by sponging miR-23c.
Li N; Jia T; Li YR
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1325-1337. PubMed ID: 32096162
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-130b improves renal tubulointerstitial fibrosis via repression of Snail-induced epithelial-mesenchymal transition in diabetic nephropathy.
Bai X; Geng J; Zhou Z; Tian J; Li X
Sci Rep; 2016 Feb; 6():20475. PubMed ID: 26837280
[TBL] [Abstract][Full Text] [Related]
18. Tongxinluo ameliorates renal structure and function by regulating miR-21-induced epithelial-to-mesenchymal transition in diabetic nephropathy.
Wang JY; Gao YB; Zhang N; Zou DW; Xu LP; Zhu ZY; Li JY; Zhou SN; Cui FQ; Zeng XJ; Geng JG; Yang JK
Am J Physiol Renal Physiol; 2014 Mar; 306(5):F486-95. PubMed ID: 24370587
[TBL] [Abstract][Full Text] [Related]
19. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
[TBL] [Abstract][Full Text] [Related]
20. YY1: A novel therapeutic target for diabetic nephropathy orchestrated renal fibrosis.
Yang T; Shu F; Yang H; Heng C; Zhou Y; Chen Y; Qian X; Du L; Zhu X; Lu Q; Yin X
Metabolism; 2019 Jul; 96():33-45. PubMed ID: 31028762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]